Lawrence Pharmacy Resolves Allegations That It Failed To Keep Proper Records And Maintain Proper Controls

BOSTON – The U.S. Attorney’s Office announced today that Perrotta Pharmacy Inc., DBA Perrotta’s Super Drug, in Lawrence has agreed to pay $30,000 and enter into a Corrective Action Plan with the government to resolve allegations that Perrotta’s Super Drug failed to keep proper records of controlled substances and maintain effective controls against drug diversion.

According to the settlement, pharmacists and staff at Perrotta’s Super Drug on multiple occasions failed to comply with recordkeeping requirements of the Controlled Substances Act. The violations included failure to maintain complete and accurate inventories of controlled substances, including medications such as oxycodone; failure to record all of the required information pertaining to listed chemical retail sales; and failure to maintain records documenting the training of sales personnel of listed chemical products.

Perrotta’s Super Drug, an independently owned pharmacy, cooperated with the federal investigation and has agreed to implement a corrective action plan to come into compliance with the recordkeeping requirements of the Controlled Substance Act. Perrotta’s Super Drug also agreed to permit federal law enforcement to perform inspections of the pharmacy during the next three years without a warrant. 

United States Attorney Andrew E. Lelling and Brian D. Boyle, Special Agent in Charge of the Drug Enforcement Administration, New England Division, made the announcement today. The case was handled by Assistant U.S. Attorney Jessica Weber of Lelling’s Civil Division.